735 results on '"Tollefson, Matthew K."'
Search Results
2. Surgeons’ dominant surgical modality: Impacts on wellbeing, burnout, and interventions for neuromusculoskeletal disorders
3. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
4. Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?
5. Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy
6. Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series
7. Effect of Surgical Care Team Consistency During Urologic Procedures on Surgical Efficiency and Perioperative Outcomes
8. Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy
9. PD34-06 CHANGES IN BODY COMPOSITION FOLLOWING NEOADJUVANT CHEMOTHERAPY FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY
10. PD34-03 INTRAOPERATIVE TRANEXAMIC ACID IN RADICAL CYSTECTOMY: IMPACT ON BLEEDING, THROMBOEMBOLISM, AND CANCER-SPECIFIC SURVIVAL
11. MP12-16 NATIONAL TRENDS IN SAME DAY DISCHARGE FOR RADICAL PROSTATECTOMY: AN EVOLUTION IN PRACTICE PATTERNS
12. MP77-18 PREDICTORS OF PELVIC RECURRENCE AFTER RADICAL CYSTECTOMY: IDENTIFYING THE IDEAL CANDIDATE FOR ADJUVANT RADIATION CLINICAL TRIALS
13. MP60-07 PREDICTORS OF RESPONSE TO METASTASIS DIRECTED THERAPY (MDT) IN PROSTATE CANCER PATIENTS WITH SOLITARY METASTASES TREATED WITH MDT
14. MP60-14 SURVIVAL PATTERNS BASED ON SITE-SPECIFIC VISCERAL METASTASIS IN METASTATIC PROSTATE CANCER PATIENTS: ARE OUTCOMES OF VISCERAL METASTASES THE SAME?
15. MP07-09 AUTOMATED SURGICAL STEP RECOGNITION IN TRANSURETHRAL BLADDER TUMOR RESECTION USING ARTIFICIAL INTELLIGENCE: TRANSFER LEARNING ACROSS SURGICAL MODALITIES
16. MP24-15 COMPARING FRAILTY INDICES FOR RISK STRATIFICATION IN UROLOGIC SURGERY: WHICH INDEX TO CHOOSE?
17. MP47-08 IMPACT OF HYPOGONADISM ON RADICAL CYSTECTOMY OUTCOMES
18. Automated surgical step recognition in transurethral bladder tumor resection using artificial intelligence: transfer learning across surgical modalities
19. IMPACT OF PROSTATE SIZE ON THE OUTCOMES OF RADICAL PROSTATECTOMY
20. Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy
21. Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical Prostatectomy
22. Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
23. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients with Variant Histology Undergoing Radical Cystectomy
24. The Association of Aspirin Use with Survival Following Radical Cystectomy
25. The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy
26. Utilization and Outcomes of Radical Cystectomy for High-grade Non–muscle-invasive Bladder Cancer in Elderly Patients
27. Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant Chemotherapy
28. A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease
29. A Survey of Perceptions and Acceptance of Wearable Technology for Health Monitoring in a Urological Patient Population
30. Impact of intraoperative tranexamic acid use on overall survival and cancer specific survival in patients undergoing radical cystectomy.
31. Safety of intraoperative tranexamic acid use on the risk of venous thromboembolism (VTE) in patients undergoing robotic assisted radical cystectomy (RARC).
32. Screening Postoperative Hemoglobin after Robot-Assisted Radical Prostatectomy—Frequently Used, but Is It Necessary?
33. Perioperative outcomes of robot-assisted laparoscopic partial cystectomy
34. The use of PET/CT in prostate cancer
35. Reply by Authors
36. Vesicourethral Anastomotic Stenosis Following Radical prostatectomy: Risk Factors, Natural History, and Treatment Outcomes
37. MP11-10 ISOLATED IN-FIELD RECURRENCE FOLLOWING RADICAL PROSTATECTOMY AND RADIATION
38. MP72-13 AI CHARACTERIZATION OF LONGITUDINAL CHANGES IN BODY COMPOSITION: PREDICTORS OF CHANGE AFTER RADICAL CYSTECTOMY
39. MP65-16 AI DRIVEN ASSESSMENT OF BODY COMPOSITION PARAMETERS IN RADICAL CYSTECTOMY PATIENTS: PREDICTORS OF 90-DAY COMPLICATIONS
40. Legend for Supplemental Figure 2legend from Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
41. Safety and Efficacy of Extended Duration of Thromboembolic Prophylaxis Following Radical Cystectomy: An Initial Institutional Experience
42. Robot-Assisted Cystectomy: Getting Started: Prior Experience, Learning Curve, and Initial Patient Selection
43. Factors associated with poor survival outcomes in patients with prostate cancer (PCa) with radiographic disease progression in the setting of low PSA.
44. Survival patterns based on site-specific visceral metastasis in patients with metastatic prostate cancer: Are outcomes of visceral metastases the same?
45. Mortality after Radical Cystectomy: Impact of Obesity Versus Adiposity after Adjusting for Skeletal Muscle Wasting
46. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes
47. Oncologic surveillance following radical cystectomy: an individualized risk-based approach
48. Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors
49. Diabetes Mellitus is Independently Associated with an Increased Risk of Mortality in Patients with Clear Cell Renal Cell Carcinoma
50. Intraoperative Blood Transfusion is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.